(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|
Turnover | 10.61%8.81B | 18.90%16.97B | 18.59%7.97B | 41.43%14.27B | 64.76%6.72B | 66.43%10.09B | --4.08B | 86.56%6.06B | --3.25B |
Operating income | 10.61%8.81B | 18.90%16.97B | 18.59%7.97B | 41.43%14.27B | 64.76%6.72B | 66.43%10.09B | 4.08B | 86.56%6.06B | 3.25B |
Cost of sales | -10.92%-7.93B | -18.62%-15.23B | -17.29%-7.15B | -39.87%-12.84B | -66.27%-6.1B | -68.25%-9.18B | ---3.67B | -80.55%-5.46B | ---3.02B |
Operating expenses | -10.92%-7.93B | -18.62%-15.23B | -17.29%-7.15B | -39.87%-12.84B | -66.27%-6.1B | -68.25%-9.18B | -3.67B | -80.55%-5.46B | -3.02B |
Gross profit | 7.90%881.72M | 21.34%1.74B | 31.31%817.18M | 57.00%1.43B | 51.32%622.33M | 50.11%913.83M | 411.27M | 165.98%608.79M | 228.89M |
Selling expenses | -11.43%-707.55M | -4.65%-1.39B | -1.40%-634.95M | -24.61%-1.33B | -36.60%-626.15M | -46.45%-1.06B | ---458.38M | -20.33%-726.42M | ---603.67M |
Administrative expenses | -15.80%-169.67M | -15.97%-332.6M | -12.64%-146.51M | -38.54%-286.79M | -33.78%-130.08M | -32.51%-207.01M | ---97.23M | -52.27%-156.22M | ---102.59M |
Research and development expenses | -14.37%-45.68M | -18.26%-93.6M | -11.33%-39.94M | -39.81%-79.15M | -44.38%-35.87M | -128.97%-56.61M | ---24.85M | -8.56%-24.72M | ---22.78M |
Revaluation surplus | ---- | -144.09%-3.17B | -512.83%-3.17B | -909.74%-1.3B | -136.07%-517.58M | 56.28%-128.7M | ---219.25M | 49.29%-294.33M | ---580.46M |
-Changes in the fair value of other assets | ---- | -144.09%-3.17B | -512.83%-3.17B | -909.74%-1.3B | -136.07%-517.58M | 56.28%-128.7M | ---219.25M | 49.29%-294.33M | ---580.46M |
Impairment and provision | -81.92%436K | 210.43%2.54M | 223.57%2.41M | -30.02%-2.3M | 15.17%-1.95M | 43.86%-1.77M | ---2.3M | -115.09%-3.15M | ---1.47M |
-Other impairment is provision | -81.92%436K | 210.43%2.54M | 223.57%2.41M | -30.02%-2.3M | 15.17%-1.95M | 43.86%-1.77M | ---2.3M | -115.09%-3.15M | ---1.47M |
Special items of operating profit | 52,806.31%58.73M | -42.01%41.76M | -99.78%111K | 45.53%72.02M | 182.52%50.25M | 64.53%49.49M | --17.79M | -30.75%30.08M | --43.44M |
Operating profit | 100.57%17.99M | -115.26%-3.2B | -396.61%-3.17B | -200.59%-1.49B | -71.35%-639.06M | 12.61%-494.58M | -372.95M | 45.51%-565.97M | -1.04B |
Financing cost | -6.44%-5.27M | 1.95%-10.03M | 3.03%-4.95M | -20.45%-10.23M | -25.26%-5.11M | 17.54%-8.49M | ---4.08M | -24.59%-10.3M | ---8.27M |
Earning before tax | 100.40%12.72M | -114.46%-3.21B | -393.44%-3.18B | -197.54%-1.5B | -70.85%-644.17M | 12.70%-503.07M | -377.03M | 44.95%-576.27M | -1.05B |
Tax | -67.75%636K | 216.37%3.69M | 1,295.15%1.97M | -318.09%-3.17M | -117.03%-165K | -68.12%1.45M | --969K | 236.85%4.56M | --1.35M |
After-tax profit from continuing operations | 100.42%13.35M | -113.76%-3.21B | -393.01%-3.18B | -199.04%-1.5B | -71.34%-644.33M | 12.26%-501.62M | -376.06M | 45.32%-571.71M | -1.05B |
Earning after tax | 100.42%13.35M | -113.76%-3.21B | -393.01%-3.18B | -199.04%-1.5B | -71.34%-644.33M | 12.26%-501.62M | -376.06M | 45.32%-571.71M | -1.05B |
Minority profit | -6.02%-8.47M | -52.38%-17.3M | 6.65%-7.99M | -49.76%-11.35M | -4,474.33%-8.55M | ---7.58M | ---187K | ---- | ---- |
Profit attributable to shareholders | 100.69%21.82M | -114.23%-3.19B | -398.38%-3.17B | -201.33%-1.49B | -69.15%-635.78M | 13.59%-494.04M | -375.87M | 45.32%-571.71M | -1.05B |
Basic earnings per share | 100.13%0.03 | 30.47%-8.26 | -367.46%-23.7 | -201.52%-11.88 | 57.75%-5.07 | 13.60%-3.94 | -12 | 86.34%-4.56 | -33.37 |
Diluted earnings per share | 100.13%0.03 | 30.47%-8.26 | -367.46%-23.7 | -201.52%-11.88 | 57.75%-5.07 | 13.60%-3.94 | -12 | 86.34%-4.56 | -33.37 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data